Solasonine ameliorates cerebral ischemia-reperfusion injury via suppressing TLR4/MyD88/NF-κB pathway and activating AMPK/Nrf2/HO-1 pathway
International Immunopharmacology · 2023-11 · 124 · 110862
DOI: 10.1016/j.intimp.2023.110862 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-11. Verfasst von Kang Huo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Deartment of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, PR China; Center of Brain Health,…. Hauptthemen laut MEDLINE: Reperfusion Injury, Neuroprotective Agents, Infarction, Middle Cerebral Artery, Brain Ischemia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Basic Research Program of Shaanxi Province.
Abstract (Originalsprache)
Solasonine (SS), the main active ingredient of Solanum nigrum L., has been reported to possess a variety of pharmacological properties. A recent study demonstrated a neuroprotective effect of SS in a mouse nerve injury model. However, its protective effects on cerebral ischemia/reperfusion injury (CIRI) remain to be elucidated. We investigated herein the in vitro and in vivo neuroprotective effects of SS. Primary hippocampal neurons were exposed to oxygen and glucose deprivation/reoxygenation (OGD/R) to construct an in vitro model while rats were treated with middle cerebral artery occlusion/reperfusion (MCAO/R) to establish an in vivo CIRI model. The results showed that SS reduced OGD/R-induced inflammatory responses of neurons by blocking secretion of TNF-α, IL-1β and IL-6. Moreover, SS ameliorated OGD/R-induced oxidative stress in neurons by decreasing the level of ROS and MDA and increasing the activity of SOD and GPx. We also found that SS protected neurons from OGD/R-induced apoptosis by down-regulating bax and cleaved caspase-3 and up-regulating bcl-2. The in vivo results revealed that SS administration reduced the infarct volume and alleviated the neurological deficit of MCAO/R rats as well as diminished neuronal damages in these rats. Our investigation on the underlying mechanisms indicated that the neuroprotective effect of SS on CIRI may be associated with the TLR4/MyD88/NF-κB and AMPK/Nrf2/HO-1 pathways. Taken together, these findings demonstrate that SS ameliorates CIRI via suppressing TLR4/MyD88/NF-κB pathway and activating AMPK/Nrf2/HO-1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Deartment of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, PR China; Center of Brain Health, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710…
- Department of Emergency, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, PR China.
- Deartment of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, PR China.
- Institute of Neurobiology, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi Province, PR China.
- Deartment of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, PR China. Electronic address: hanjianfeng_xj@163.com.
Förderung
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Huo, K., Xu, J., Wei, M., Ma, K., Wang, J., & Han, J. (2023). Solasonine ameliorates cerebral ischemia-reperfusion injury via suppressing TLR4/MyD88/NF-κB pathway and activating AMPK/Nrf2/HO-1 pathway. International Immunopharmacology, 124, 110862. https://doi.org/10.1016/j.intimp.2023.110862
Vancouver
Huo K, Xu J, Wei M, Ma K, Wang J, Han J. Solasonine ameliorates cerebral ischemia-reperfusion injury via suppressing TLR4/MyD88/NF-κB pathway and activating AMPK/Nrf2/HO-1 pathway. International Immunopharmacology. 2023;124:110862. doi:10.1016/j.intimp.2023.110862
BibTeX
@article{Huo2023,
author = {Huo, Kang and Xu, Jing and Wei, Meng and Ma, Kaige and Wang, Jianyi and Han, Jianfeng},
title = {Solasonine ameliorates cerebral ischemia-reperfusion injury via suppressing TLR4/MyD88/NF-κB pathway and activating AMPK/Nrf2/HO-1 pathway},
journal = {International Immunopharmacology},
year = {2023},
volume = {124},
pages = {110862},
doi = {10.1016/j.intimp.2023.110862}
}
EUVIMED